Suppr超能文献

最大肾小球直径作为 IgA 肾病 10 年预后指标。

Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy.

机构信息

Department of Medicine, Kidney Center, Tokyo Women’s Medical University, Tokyo, Japan.

出版信息

Nephrol Dial Transplant. 2011 Dec;26(12):3937-43. doi: 10.1093/ndt/gfr139. Epub 2011 Mar 22.

Abstract

BACKGROUND

Although there have been many reports on clinicopathological studies of immunoglobulin A nephropathy (IgAN), reliable outcome predictors are still lacking. We therefore assessed maximal glomerular diameter (Max GD), an indicator of glomerular size, as a predictor of the long-term evolution of renal histopathology.

METHODS

Forty-three adult patients, diagnosed with IgAN, who had estimated glomerular filtration rate (eGFR) ≥50 mL/min/1.73 m(2), were enrolled in this study. Prognostic variables for renal survival were examined by using the multivariate Cox proportional hazards method. The optimal cut-off value of Max GD was 242.3 μm (AUC = 0.78, sensitivity = 62.5%, specificity = 81.5%) by using receiver operating characteristics analysis. In order to assess the characteristics of glomerular hypertrophy, we divided the cases into two groups according to the Max GD value (Group A, ≥242 μm; Group B, <242 μm). Renal survival was also assessed by Kaplan-Meier curves with the log-rank test.

RESULTS

The Max GD was significantly correlated with age, body mass index and serum triglyceride levels at the time of renal biopsy. During the 10-year follow-up period, the Max GD was significantly correlated with eGFR decline per year, and proteinuria, but not with hematuria. A multiple regression analysis by the Cox method adjusted for age, sex and eGFR showed that the Max GD values were significantly associated with a 1.5-fold increase in serum creatinine (Cr) values (hazard ratio = 1.04, P = 0.03). Renal function in 66.7% of the patients whose Max GD was ≥242 μm had at least a 1.5-fold increase in their serum Cr value at the 10-year follow-up examination (log-rank, P = 0.003).

CONCLUSIONS

The results of this study suggest that Max GD is a simple quantitative prognostic indicator of the disease progression in IgAN patients.

摘要

背景

尽管已有许多关于免疫球蛋白 A 肾病(IgAN)临床病理研究的报道,但仍缺乏可靠的预后预测指标。因此,我们评估了肾小球最大直径(Max GD)作为肾小球大小的指标,作为预测肾脏组织病理学长期演变的指标。

方法

本研究纳入了 43 名成人 IgAN 患者,这些患者估算肾小球滤过率(eGFR)≥50 mL/min/1.73 m²。使用多变量 Cox 比例风险方法检查肾脏生存的预后变量。使用受试者工作特征(ROC)分析确定 Max GD 的最佳截断值为 242.3 μm(AUC=0.78,灵敏度=62.5%,特异性=81.5%)。为了评估肾小球肥大的特征,我们根据 Max GD 值将病例分为两组(A 组,≥242 μm;B 组,<242 μm)。通过 Kaplan-Meier 曲线和对数秩检验评估肾脏存活率。

结果

在肾脏活检时,Max GD 与年龄、体重指数和血清三酰甘油水平显著相关。在 10 年的随访期间,Max GD 与每年 eGFR 下降显著相关,与蛋白尿相关,但与血尿无关。Cox 方法的多变量回归分析校正年龄、性别和 eGFR 后显示,Max GD 值与血清肌酐(Cr)值增加 1.5 倍显著相关(风险比=1.04,P=0.03)。Max GD 值≥242 μm 的患者中有 66.7%的患者在 10 年随访时其血清 Cr 值至少增加了 1.5 倍(对数秩,P=0.003)。

结论

本研究结果表明,Max GD 是 IgAN 患者疾病进展的简单定量预后指标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验